Follow Chr. Hansen A/S

Tags

Chr. Hansen 68 probiotics 15 food 13 dairy 12 consumers 9 Natural Colors 7 beverage 5 innovation 4 communication 4 cheese 4 bb-12® 4 marketing 3 lgg® 3 images 3 annual report 3 Q2 3 Cees de Jong 2 financial results 2 press 2 C20 2 lactose intolorant 2 feed 2 poultry 2 lactose 2 interim report 2 animal health 2 lactose-free 2 financial report 2 award 2 q3 1 sugar 1 transparency 1 probiotic 1 ingredients 1 organizational 1 natural solutions 1 conversion 1 cottage cheese 1 regnskab 1 yogurt 1 H1 1 game changer 1 food waste 1 dietary supplements 1 valio 1 idf 1 label 1 colors 1 product 1 financials 1 dial 1 natural colours 1 confectionary 1 infant formula 1 kefir 1 carmine 1 human microbiome 1 second generation 1 financial result 1 microbiome 1 cultures 1 l.casei 431 1 white cheese 1 greek feta 1 direct vat set 1 fermentation 1 ripening culture 1 GalliPro® Max 1 microbial 1 dairy alternatives 1 plant health 1 soft cheese 1 2016/17 1 plant based 1 UN goals 1 bioprotection 1 FreshQ 1 Natural color 1 coloring foodstuff 1 natural colour 1 colouring foodstuff 1 LGG 1 childrens' product 1 drinking yogurt 1 communincation 1 dvs white classic 1 DVS® FRESCO® 1000 1 SCiO 1 Consumer Physics 1 feed analysis 1 Q2 2017/18 1 sustainability 1 test 1 salt 1 iso 1 standard 1 clinical trial 1 growth 1 new 1 acquisition 1 clean 1 corporate responsibility 1 wine 1 Q1 1 flow cytometry 1 cfo 1 change 1 bacteria 1 children 1 financial 1 leadership 1 culture 1 kids 1 livestock 1 report 1 results 1 natural 1 delight 1 quarterly result 1 Show all tags
New clinical study indicates: probiotics may shorten duration of common cold and lower use of health care resources

New clinical study indicates: probiotics may shorten duration of common cold and lower use of health care resources

Press Releases   •   May 21, 2015 06:57 GMT

With the completion and publication of the world’s largest clinical study on the immune effect of probiotics in adults, Chr. Hansen has obtained results indicating that the probiotic strain named L. CASEI 431® can shorten the duration of common cold and influenza-like illness, lower the use of health care resources and reduce use of antibiotics.